about
Elucidating the immunological function of the Cryptococcus neoformans capsuleGlucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophagesPeptides of the constant region of antibodies display fungicidal activityAntibody complementarity-determining regions (CDRs): a bridge between adaptive and innate immunity.Antifungal and immunomodulating activities of 1,4-benzothiazine azole derivatives: review.Evaluation of anti-Candida activity of Vitis vinifera L. seed extracts obtained from wine and table cultivarsRole of CD45 signaling pathway in galactoxylomannan-induced T cell damage.Involvement of glycoreceptors in galactoxylomannan-induced T cell death.Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection.Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferasesTh17 cells and IL-17 in protective immunity to vaginal candidiasis.Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.Cytotoxic T lymphocyte antigen costimulation influences T-cell activation in response to Cryptococcus neoformans.Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.Immunoregulation by capsular components of Cryptococcus neoformans.Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.Functional improvement of regulatory T cells from rheumatoid arthritis subjects induced by capsular polysaccharide glucuronoxylomannogalactan.Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway.The cellular responses induced by the capsular polysaccharide of Cryptococcus neoformans differ depending on the presence or absence of specific protective antibodies.Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry.The microbial capsular polysaccharide galactoxylomannan inhibits IL-17A production in circulating T cells from rheumatoid arthritis patients.Sch9 kinase integrates hypoxia and CO2 sensing to suppress hyphal morphogenesis in Candida albicans.Induction of caspase-11 by aspartyl proteinases of Candida albicans and implication in promoting inflammatory response.Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytesSecretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesAspartyl Proteinases of Eukaryotic Microbial Pathogens: From Eating to HeatingAn anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.Glucuronoxylomannan exhibits potent immunosuppressive properties.The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus.A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine productionA novel bioluminescence mouse model for monitoring oropharyngeal candidiasis in mice.Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity.In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans.A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections.Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis.Microbial polysaccharide: new insights for treating autoimmune diseases.Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy.Capsular Material of Cryptococcus neoformans: Virulence and Much More.Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-Hodgkin lymphoma: a case report.
P50
Q26859234-D25EFE80-ADE4-4E93-9F43-98A9CEF119ECQ28297961-FFF69EC1-0BC1-4216-B640-6C313EADC3ADQ28730940-DF245A5B-4B7B-47F4-B201-986995FADF6BQ30974285-F40C502B-C693-4993-9C76-9645528AD012Q32100806-C7B97A50-8028-4BEC-A6E7-EFD115AE29AEQ33598045-39977E1B-02BA-4D94-900F-FDE5B7CCC44AQ33697916-ECBC405B-0A26-44E5-8248-F013EAB07AAAQ33715053-4B5C6C83-DD9A-4A8B-9169-B6826E9B4929Q33830972-A152C93B-DCC6-4F38-9DA7-FFB3776D447DQ33946702-066C2E22-D095-4443-A1ED-89C966C8432FQ33983438-F8C4D02F-02B4-4A19-A18F-4C8179C5F2B3Q34003199-C1AB1AB9-7E05-478A-BD54-336DF540E40BQ34006313-B7EF1D35-63FC-4981-A79F-97294DD73272Q34125581-8279EFE2-FB4D-4029-A483-AB803A70D3DDQ34155052-8F1CBA0A-7A03-4ECE-A812-85D7D94ED16CQ34259300-A2424C87-CA24-4AD6-90B5-B204D7A796D7Q34388690-C41C7F49-1D5F-4AC6-900D-E4EE337D2E96Q34405961-B1104982-C710-42F9-9972-CD0CFDDD3215Q34428843-9D7D69A5-483C-424D-961D-D9F1B94A2A4EQ34486439-68A1453B-DA86-49E9-8DE6-E6D33E25D98DQ34544926-D3CB3497-35DC-4A28-8B71-9BEEC696DEA7Q35080839-D60A5DAC-563D-49DE-9B99-65AF46D4E29DQ35439961-C3ADCFE9-E2BA-4040-AED9-2D569994A6EEQ35507864-91F163BD-3E67-4499-A0FE-AE9646945C92Q35650359-8F12EFC4-9A9C-4610-B0F7-050EC3D8F7C0Q36158337-3C23D53E-1430-45B5-BFBB-F71E7231A4D8Q36231575-73C801F0-54C5-437D-8DFF-82FC106276F1Q36313815-D1C8F2AD-EF47-468E-9BB1-07780EB90C5CQ36476696-EFAC57D1-BB65-4F82-BF25-F8405CBB052CQ36539579-7FB32991-2280-437D-B364-87BF7A3A8430Q36845263-32225DB0-8A35-4804-B432-C6E31CC88E08Q37014780-0AC4A6B0-3191-49D2-B617-9C19A5BF968AQ37058088-B0C6C27B-3055-4CBC-93B9-8C788712A055Q37268449-4D7A46C9-BB13-4C71-BC92-3CF0C4CD2B0DQ37410305-08270435-E357-4624-9923-76AE47B449F3Q37582905-42935C90-B788-4FFA-8C79-DF9492951A3AQ37663344-481EAFC4-C675-4C0D-BA6C-E8484A7FCE24Q37917789-6D66E7A2-679E-4386-AEF0-EA6B9BFE90E4Q37982326-945538F7-C5B7-4E3E-9FFE-CC4FB110DAF6Q38541872-744D5D9A-52EA-4555-BDC3-6ED7996CA46D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Vecchiarelli
@ast
Anna Vecchiarelli
@en
Anna Vecchiarelli
@es
Anna Vecchiarelli
@nl
type
label
Anna Vecchiarelli
@ast
Anna Vecchiarelli
@en
Anna Vecchiarelli
@es
Anna Vecchiarelli
@nl
prefLabel
Anna Vecchiarelli
@ast
Anna Vecchiarelli
@en
Anna Vecchiarelli
@es
Anna Vecchiarelli
@nl
P106
P2038
Anna_Vecchiarelli
P21
P31
P496
0000-0002-3185-6720